XML 88 R66.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Taxes [Line Items]    
Orphan drug tax credit carryforwards $ 26,885,000 $ 24,983,000
Deferred tax assets, capitalization of section 174 costs 21,800,000 16,900,000
Valuation allowance 210,112,000 198,212,000
Increase in valuation allowance 11,900,000 13,500,000
Unrecognized tax benefits 0 0
Uncertain tax position 0  
Federal    
Income Taxes [Line Items]    
Net operating loss 84,500,000  
Federal | Research and Experimentation    
Income Taxes [Line Items]    
Research and experimentation credit carryforwards 14,000,000.0 12,900,000
Federal | Tax Years 2025 through 2038    
Income Taxes [Line Items]    
Net operating loss 32,100,000  
State    
Income Taxes [Line Items]    
Net operating loss 19,600,000  
State | Research and Experimentation    
Income Taxes [Line Items]    
Research and experimentation credit carryforwards $ 4,200,000 $ 4,100,000